1 DBV and Societé des Produits Nestlé S.A (formerly NESTEC S.A.) (“NESTEC”) agreed to terminate the Development Collaboration and License Agreement, pursuant to which this study was conducted, on ...

DBV Technologies is headquartered in Châtillon, France, with North American operations in Warren, NJ. The Company's ordinary ...

DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT - CUSIP: 23306J309) ...

Behind The Count Of 891 Asiatic Lions In Gujarat Lies An Extraordinary Operation Involving Thousands Of Searchers Who Divided ...

After 12 months of treatment ... impairment charge related to the takeover in its fourth quarter 2022 results. DBV said recently it has confirmation from the FDA that the efficacy results of ...

The VIASKIN peanut patch (VP250) is safe and effective for children aged 1 to 3 years who have peanut allergy, with and without atopic comorbidities.

Love it or hate it, Croatia is a success story like no other. From war-ravaged in the 90s, to Europe's hottest summer ...

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company (the “Company”), held its Combined General Meeting (the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...